SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000914190-12-000244
Filing Date
2012-04-02
Accepted
2012-04-02 15:27:06
Documents
1
Period of Report
2012-03-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 22237
  Complete submission text file 0000914190-12-000244.txt   23859
Mailing Address 4 WEST 4TH AVE SUITE 400 SAN MATEO CA 94402
Business Address 4 WEST 4TH AVE SUITE 400 SAN MATEO CA 94402 650-458-2678
Nile Therapeutics, Inc. (Issuer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 787 7TH AVE 48TH FLOOR NEW YORK NY 10019
Business Address
Kazam Joshua A (Reporting) CIK: 0001221355 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34058 | Film No.: 12733066